Recent Finacing
Recent Raise
Henlius is a biopharmaceutical company developing monoclonal antibody therapeutics and biosimilars for oncology and immune diseases, with multiple programs progressing through clinical and late-stage trials in China.
Focus Areas
Recent Investors
Valuation as of 01/17/2018
Total Raised
Funding round
Investor
See the team members at Shanghai Henlius Biotech.
